Table 1 Characteristics at baseline and last follow‐up.
| Demographics | Preinjection status | Last follow‐up status | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient ID | Age (years) | Eye | Previous treatment | VA | RE (diopter) | CFT (μm) | Days | INJ | VA | CFT (μm) | Diff CFT (μm) |
| 1 | 70 | R | None | 20/70 | −5.50 | 253 | 35 | 1 | 20/50 | 142 | −111 |
| 2 | 57 | R | None | 20/60 | −7.25 | NA | 98 | 1 | 20/30 | 205 | NA |
| 3 | 65 | L | None | 20/400 | −9.00 | 664 | 110 | 1 | 20/200 | 308 | −356 |
| 4 | 38 | R | None | 20/400 | NA | 289 | 121 | 1 | 20/200 | 195 | −94 |
| 5 | 58 | L | PDTx2 | 20/200 | −10.00 | 269 | 147 | 2 | 20/400 | 273 | 4 |
| 6 | 44 | R | PDTx1 | 20/60 | −11.25 | 380 | 161 | 1 | 20/40 | 240 | −140 |
| 6 | 44 | L | PDTx1 | 20/70 | −12.50 | 373 | 175 | 1 | 20/40 | 270 | −103 |
| 7 | 67 | L | None | 20/80 | IOL | 253 | 203 | 1 | 20/30 | 240 | −13 |
| 8 | 51 | R | None | 20/100 | −8.50 | 276 | 203 | 2 | 20/20 | 215 | −61 |
| 8 | 51 | L | PDTx2 | 20/400 | −8.75 | 318 | 224 | 2 | 20/30 | 223 | −95 |
| 9 | 47 | L | PDTx2 | 20/200 | IOL | 327 | 210 | 1 | 20/40 | 265 | −62 |
CFT, central foveal thickness; Diff CFT, difference in central foveal thicknesses compared with initial presentation; ID, identification number; INJ, injection(s); IOL, intraocular lens; L, left; NA, not available; PDT, photodynamic therapy; R, right; RE, refractive error; VA, visual acuity.